Download Full Text (19.6 MB)


  • Multidisciplinary Team Helps Patients with Cancer Overcome Cognitive Problems
  • Protocols: Studies Focus on Cognitive Effects of Cancer and Its Treatment
  • House Call: Simple Steps Can Put Patients on the Road to Well-Being
  • Highly Selective Synthetic Binding Agents Target Different DNA Conformations

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Meyers, Christina A.; Kayl, Anne E.; Groves, Morris; Priebe, Waldemar, 1948-; Chaires, Jonathan; Trent, John O.; Fokt, Izabela; Dziewiszek, Joanna; Lee, Sangkyou; Szymanski, Slawonir; Harle, Margaret; Kosinski, Szymon; DNA, Z-Form; DNA; Corpus Callosum; Magnetic Resonance Imaging; Donepezil; Methylphenidate; Brain Neoplasms; Clinical Trials as Topic; Neuropsychological Tests; Neuropsychology; Cytokines; Chemotherapy, Adjuvant; Radiotherapy -- adverse effects; Immunotherapy -- adverse effects; Chemotherapy-Related Cognitive Impairment; Neurotoxicity Syndromes; Neurological Rehabilitation; RNA Editing; Adenosine Deaminase; Allosteric Regulation; DNA-Binding Proteins; WP 631; Daunorubicin -- analogs & derivatives; MCF-7 Cells; Breast Neoplasms; SP1 protein, human; Sp1 Transcription Factor; WP760; Anthracyclines; Y-Box-Binding Protein 1; Psychological Well-Being; Health; Index.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 46, Number 11/12, November-December 2001